Results 121 to 130 of about 38,385 (346)
Pemberian Kombinasi Vitamin B1, B6 dan B12 sebagai Faktor Determinan Penurunan Nilai Total Gejala pada Pasien Neuropati Perifer Diabetik [PDF]
, 2016 Diabetic neuropathy is defined as symptoms of peripheral nerve dysfunction in people with diabetes after the exclusion of other causes. According to the earlier studies symptoms of neuropathy such as pain, burning, paresthesia/tingling and numbness can ...
Dewi, R. S. (Ratna) +2 more
core +3 more sources
Exploring the Anti‐Diabetic Potential of Anthocyanins: From Biochemical Pathways to Human Trials
Chronic Diseases and Translational Medicine, EarlyView.ABSTRACT Diabetes mellitus (DM) is a global health challenge with increasing prevalence rates, particularly in low‐ and middle‐income countries. Anthocyanins (ACs) are potential bioactive compounds found in various fruits and vegetables, attracting the attention of researchers due to their possible role in managing diabetes and its complications ...
Lakshay Panchal +6 more
wiley +1 more source
The Prevalence and Implications of Polypharmacy in Individuals With Type 1 Diabetes
Clinical Pharmacology &Therapeutics, EarlyView.Polypharmacy is increasingly recognized as a relevant issue in diabetes care, but its prevalence and clinical relevance in individuals with type 1 diabetes remain underexplored. This study aimed to determine the prevalence of polypharmacy and to identify associated clinical and psychological factors. Participants were recruited from a tertiary diabetes
Namam Ali +4 more
wiley +1 more source
The Egyptian Journal of Neurology, Psychiatry and NeurosurgeryBackground Diabetic peripheral neuropathy is regarded as one of the most common microvascular sequalae of type 2 diabetes mellitus which leads to lower limb complications.
Mary Fayez Francis Hana +3 more
doaj +1 more source
Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma
Clinical Pharmacology &Therapeutics, EarlyView.Extended interval dosing regimens of immune checkpoint inhibitors have been implemented widely. However, their approval was mainly based on pharmacokinetic modeling and simulations. Consequently, comparative safety data of extended interval dosing regimens in a real‐world setting are limited.
Ruben Malmberg +10 more
wiley +1 more source
HIV-related neuropathy: current perspectives [PDF]
, 2013 Sonja G Schütz, Jessica Robinson-Papp Department of Neurology, Mount Sinai School of Medicine, New York, NY, USA Abstract: Distal symmetric polyneuropathy (DSP) related to human immunodeficiency virus (HIV) is one of the most common neurologic ...
Robinson-Papp J, Sch&
core +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.Pregabalin and duloxetine are widely prescribed non‐opioid medications for chronic musculoskeletal pain. Pregabalin may increase the risk of heart failure, and duloxetine increases heart rate and blood pressure; however, little is known about their comparative cardiovascular safety.
Sachalee Campbell +11 more
wiley +1 more source
Accuracy of machine learning for differentiation between optic neuropathies and pseudopapilledema
BMC Ophthalmology, 2019 Background This study is to evaluate the accuracy of machine learning for differentiation between optic neuropathies, pseudopapilledema (PPE) and normals.
Jin Mo Ahn +4 more
doaj +1 more source
Teleneurology clinics for polyneuropathy: a pilot study. [PDF]
, 2020 INTRODUCTION:Polyneuropathy (PN) is a common condition with significant morbidity. We developed tele-polyneuropathy (tele-PN) clinics to improve access to neurology and increase guideline-concordant PN care.
Cheng, Eric M +7 more
core